Education
About Us
Working with TipRanks
Follow Us
MaxCyte (MXCT) (MXCT)
:MXCT
Total Valuation
MaxCyte has a market cap or net worth of $280.97M. The enterprise value is $302.63M.
Market Cap$280.97M
Enterprise Value$302.63M
Share Statistics
MaxCyte has 106.03M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding106.03M
Owned by Insiders1.39%
Owned by Instutions0.37%
Financial Efficiency
MaxCyte’s return on equity (ROE) is -0.20 and return on invested capital (ROIC) is -22.80%.
Return on Equity (ROE)-19.91%
Return on Assets (ROA)-17.14%
Return on Invested Capital (ROIC)-22.80%
Return on Capital Employed (ROCE)-22.89%
Revenue Per Employee$338,842.105
Profits Per Employee-$360,131.579
Employee Count114
Asset Turnover0.16
Inventory Turnover0.80
Valuation Ratios
The current PE Ratio of MaxCyte is -10.62. MaxCyte’s PEG ratio is -1.97.
PE Ratio-10.62
PS Ratio11.29
PB Ratio2.11
Price to Fair Value2.11
Price to FCF-14.91
Price to Operating Cash Flow-15.80
PEG Ratio-1.97
Income Statement
In the last 12 months, MaxCyte had revenue of $38.63M and earned -$41.05M in profits. Earnings per share was -$0.39.
Revenue$38.63M
Gross Profit$29.43M
Operating Income-$51.14M
Pretax Income-$41.05M
Net Income-$41.05M
EBITDA-46.41M
Earnings Per Share (EPS)-0.39
Cash Flow
In the last 12 months, operating cash flow was -$27.61M and capital expenditures -$1.65M, giving a free cash flow of -$29.26M billion.
Operating Cash Flow-$27.61M
Free Cash Flow-$29.26M
Free Cash Flow per Share-$0.28
Dividends & Yields
MaxCyte pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-6.71%
Earnings Yield-9.41%
Stock Price Statistics
Beta1.37
52-Week Price Change-34.28%
50-Day Moving Average3.31
200-Day Moving Average3.89
Relative Strength Index (RSI)39.20
Average Volume (3m)732.71K
Important Dates
MaxCyte upcoming earnings date is May 7, 2025, TBA.
Last Earnings DateMar 11, 2025
Next Earnings DateMay 7, 2025
Ex-Dividend Date―
Financial Position
MaxCyte as a current ratio of 10.88, with Debt / Equity ratio of 0.09
Current Ratio10.88
Quick Ratio10.32
Debt to Market Cap0.04
Net Debt to EBITDA0.21
Interest Coverage Ratio0.00
Taxes
In the past 12 months, MaxCyte has paid $1.07M in taxes.
Income Tax$1.07M
Effective Tax Rate0.00%
Enterprise Valuation
MaxCyte EV to EBITDA ratio is -9.19, with an EV/FCF ratio of -14.57.
EV to Sales11.04
EV to EBITDA-9.19
EV to Free Cash Flow-14.57
EV to Operating Cash Flow-15.44
Balance Sheet
MaxCyte has $154.48M in cash and marketable securities with $18.03M in debt, giving a net cash position of -$136.45M billion.
Cash & Marketable Securities$154.48M
Total Debt$18.03M
Net Cash-$136.45M
Net Cash Per Share-$1.29
Tangible Book Value Per Share$1.97
Margins
Gross margin is 81.62%, with operating margin of -132.54%, and net profit margin of -106.29%.
Gross Margin81.62%
Operating Margin-132.54%
Pretax Margin-106.29%
Net Profit Margin-106.29%
EBITDA Margin-120.14%
EBIT Margin-132.54%
Analyst Forecast
The average price target for MaxCyte is $7.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$7.50
Price Target Upside194.12%
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast-6.45%
EPS Growth Forecast-6.56%